$AFCG
Advanced Flower Capital Inc. Stock $afcg

$afcg Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000182252324000014 Filed on March 07, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$14.76M	$15.87M	$64.18M
YoY Change	-12.32%	-19.44%	-14.58%
Cost Of Revenue	$3.463M	$3.472M	$14.06M
YoY Change	-6.52%	-10.79%	-10.79%
Gross Profit	$11.20M	$12.40M	$48.77M
YoY Change	-14.5%	-21.57%	-17.85%
Gross Profit Margin	75.9%	78.13%	76.0%
Selling, General & Admin	$2.552M	$1.592M	$7.502M
YoY Change	-5.74%	-21.53%	-1.81%
% of Gross Profit	22.78%	12.84%	15.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$6.015M	$1.592M	$21.57M
YoY Change	-6.19%	-21.53%	-7.86%
Operating Profit	$5.187M	$10.81M	$27.21M
YoY Change	-22.47%	-21.58%	-24.35%
Interest Expense	$1.603M	-$7.361M	$6.357M
YoY Change	-3.9%	262.37%	-6.7%
% of Operating Profit	30.91%	-68.1%	23.37%
Other Income/Expense, Net	-$4.932M	-$11.98M	-$12.13M
YoY Change	602.09%	47.26%	8.55%
Pretax Income	$104.2K	-$8.535M	$22.61M
YoY Change	-98.98%	-336.13%	-38.82%
Income Tax	$158.4K	$653.4K	$1.659M
% Of Pretax Income	151.91%		7.34%
Net Earnings	-$54.12K	-$9.188M	$20.95M
YoY Change	-100.54%	-412.74%	-41.69%
Net Earnings / Revenue	-0.37%	-57.89%	32.65%
Basic Earnings Per Share	-$0.01		$1.02
Diluted Earnings Per Share	-$0.01	-$0.45	$1.02
COMMON SHARES
Basic Shares Outstanding	20.67M shares	20.46M shares	20.32M shares
Diluted Shares Outstanding	20.41M shares		20.35M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$82.30M	$121.6M	$121.6M
YoY Change	2.1%	-13.35%	-13.35%
Cash & Equivalents	$82.30M	$121.6M	$121.6M
Short-Term Investments
Other Short-Term Assets	$532.8K	$688.5K	$688.5K
YoY Change	26.82%	49.39%	49.39%
Inventory
Prepaid Expenses
Receivables	$5.690M	$1.837M	$1.837M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$88.52M	$124.2M	$124.2M
YoY Change	9.25%	-11.84%	-11.84%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$387.9M	$342.4M	$342.4M
YoY Change	5.75%	-9.49%	-9.49%
TOTAL ASSETS
Total Short-Term Assets	$88.52M	$124.2M	$124.2M
Total Long-Term Assets	$387.9M	$342.4M	$342.4M
Total Assets	$476.4M	$466.6M	$466.6M
YoY Change	6.38%	-10.13%	-10.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.045M	$714.7K	$714.7K
YoY Change	-35.13%	-14.58%	-14.58%
Accrued Expenses	$6.627M	$5.852M	$5.852M
YoY Change	-23.8%	-41.32%	-41.32%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$77.61M	$58.40M	$58.40M
YoY Change	255.97%	-28.98%	-28.98%
LONG-TERM LIABILITIES
Long-Term Debt	$88.16M	$88.01M	$88.01M
YoY Change	0.68%	-9.39%	-9.39%
Other Long-Term Liabilities	$9.140K	$115.5K	$115.5K
YoY Change	-98.44%	-84.69%	-84.69%
Total Long-Term Liabilities	$88.17M	$88.13M	$88.13M
YoY Change	0.02%	-9.97%	-9.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$77.61M	$58.40M	$58.40M
Total Long-Term Liabilities	$88.17M	$88.13M	$88.13M
Total Liabilities	$165.8M	$146.5M	$146.5M
YoY Change	50.78%	-18.65%	-18.65%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.93M	-$29.96M
YoY Change	249.95%	200.72%
Common Stock	$206.7K	$204.6K
YoY Change	0.87%	0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$310.6M	$320.1M	$320.1M
YoY Change
Total Liabilities & Shareholders Equity	$476.4M	$466.6M	$466.6M
YoY Change	6.38%	-10.13%	-10.13%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$54.12K	-$9.188M	$20.95M
YoY Change	-100.54%	-412.74%	-41.69%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$6.373M	$6.239M	$21.23M
YoY Change	45.4%	61.37%	-32.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$53.88M	$10.01M	$28.52M
YoY Change	-459.41%	-80.81%	-274.5%
Cash From Investing Activities	-$53.88M	$10.01M	$28.52M
YoY Change	-459.41%	-80.81%	-274.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$8.180M	32.17M	-$68.49M
YoY Change	-110.34%	-32.99%	-524.16%
NET CHANGE
Cash From Operating Activities	$6.373M	6.239M	$21.23M
Cash From Investing Activities	-$53.88M	10.01M	$28.52M
Cash From Financing Activities	$8.180M	32.17M	-$68.49M
Net Change In Cash	-$39.33M	48.42M	-$18.75M
YoY Change	-34.2%	-53.46%	-160.23%
FREE CASH FLOW
Cash From Operating Activities	$6.373M	$6.239M	$21.23M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1338469	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20951999	usd
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	AFC GAMMA, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-1807125
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	525 Okeechobee Blvd., Suite 1650
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33401
CY2023	dei	City Area Code CityAreaCode	561
CY2023	dei	Local Phone Number LocalPhoneNumber	510-2390
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023	dei	Trading Symbol TradingSymbol	AFCG
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001822523
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	afcg	Severance Costs Period To Receive Base Salary SeveranceCostsPeriodToReceiveBaseSalary	P12M
CY2023Q1	afcg	Severance Cobra Premiums Paid Period SeveranceCOBRAPremiumsPaidPeriod	P12M
CY2023	afcg	Share Based Compensation Arrangement By Share Based Payment Award Expiration Period Extension ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationPeriodExtension	P1Y
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	196751483	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20667094	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Name AuditorName	CohnReznick LLP
CY2023	dei	Auditor Firm AuditorFirmId	596
CY2023	dei	Auditor Location AuditorLocation	Baltimore, Maryland
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2022Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	100635985	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2220653	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	26309450	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	13538077	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	276996006	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	273859688	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	121626453	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	140372841	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1837450	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3715995	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	5257475	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	688446	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	460844	usd
CY2023Q4	us-gaap	Assets Assets	466585055	usd
CY2022Q4	us-gaap	Assets Assets	519176899	usd
CY2023Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	894000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	1036667	usd
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	16437	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	18146	usd
CY2023Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	9819695	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11403840	usd
CY2023Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	115473	usd
CY2022Q4	us-gaap	Financing Receivable Covered Allowance For Credit Loss FinancingReceivableCoveredAllowanceForCreditLoss	754128	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	3471726	usd
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	3891734	usd
CY2023Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1486256	usd
CY2022Q4	afcg	Accrued Direct Administrative Expenses AccruedDirectAdministrativeExpenses	1843652	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	714685	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	836642	usd
CY2023Q4	us-gaap	Senior Notes SeniorNotes	88014558	usd
CY2022Q4	us-gaap	Senior Notes SeniorNotes	97131777	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	42000000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	60000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	146532830	usd
CY2022Q4	us-gaap	Liabilities Liabilities	180117530	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	125	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	125	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20457697	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20457697	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20364000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20364000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	204577	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	203640	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	349805890	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	348817914	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29958243	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9962186	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	320052225	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	466585055	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	519176899	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	70535087	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	81498717	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	6814075	usd
CY2023	afcg	Accrued Exchange Fee Rebate AccruedExchangeFeeRebate	1693133	usd
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	14064305	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	15765250	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5005254	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4699676	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	21566117	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18746388	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	12132718	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	11177470	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1340476	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8513364	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3593095	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	22611336	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	36958721	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1659337	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1026324	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20951999	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20321091	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19842222	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20345919	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19957737	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20951999	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	168750	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20951999	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36101147	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	988913	usd
CY2023	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.00
CY2023	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	40933056	usd
CY2023	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	120
CY2023	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	15000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	320052225	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	273075174	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73346205	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1338549	usd
CY2022	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.23
CY2022	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	44786706	usd
CY2022	us-gaap	Preferred Stock Dividends Per Share Cash Paid PreferredStockDividendsPerShareCashPaid	120
CY2022	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	15000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	339059369	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20951999	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2023	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	12132718	usd
CY2022	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	11177470	usd
CY2023	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-1340476	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	450000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1986381	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8513364	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3593095	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	6143832	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	11763696	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	988913	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1338469	usd
CY2023	afcg	Payment In Kind Interest PaymentInKindInterest	10931732	usd
CY2022	afcg	Payment In Kind Interest PaymentInKindInterest	8369127	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	38687	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-1542717	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	844537	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	346815	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-859203	usd
CY2023	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	4700944	usd
CY2022	afcg	Increase Decrease In Interest Reserve IncreaseDecreaseInInterestReserve	2031327	usd
CY2023	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-142667	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	44827	usd
CY2023	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-420008	usd
CY2022	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	1068690	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-357396	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	519195	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-123666	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-674192	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21228934	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31321973	usd
CY2023	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	51757225	usd
CY2022	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	162885750	usd
CY2023	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	21312827	usd
CY2022	us-gaap	Proceeds From Sale Of Loans Held For Investment ProceedsFromSaleOfLoansHeldForInvestment	10600000	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15900000	usd
CY2023	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	58963777	usd
CY2022	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	120042065	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	28519379	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16343685	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	75057650	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1711365	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	225000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	578508	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	63000000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	60000000	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	81000000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	75000000	usd
CY2023	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	42532201	usd
CY2022	us-gaap	Payments Of Ordinary Dividends PaymentsOfOrdinaryDividends	41619272	usd
CY2023	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	7737500	usd
CY2022	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-68494701	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16148505	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	31126793	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140372841	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	109246048	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	121626453	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	140372841	usd
CY2023	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	1500000	usd
CY2022	afcg	Interest Reserve Withheld From Funding Of Loan InterestReserveWithheldFromFundingOfLoan	450000	usd
CY2023	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	7398475	usd
CY2022	afcg	Original Issue Discount Withheld From Funding Of Loans OriginalIssueDiscountWithheldFromFundingOfLoans	7764875	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	168750	usd
CY2023	afcg	Dividends Declared But Not Yet Paid DividendsDeclaredButNotYetPaid	9819695	usd
CY2022	afcg	Dividends Declared But Not Yet Paid DividendsDeclaredButNotYetPaid	11403840	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5549250	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5847743	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1655821	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	952524	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risks</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, loans and interest receivable. The Company places its cash and cash equivalents with financial institutions, and, at times, cash held exceeds the Federal Deposit Insurance Corporation insured limit. The Company and the Manager seek to manage this credit risk by monitoring the financial institutions and their ability to continue in business for the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has exposure to credit risk on its loans and interest receivable. The Company and the Manager seek to manage credit risk by performing due diligence prior to origination or acquisition and through the use of non-recourse financing, when and where available and appropriate.</span></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates in the Preparation of Financial Statements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value and current expected credit losses.</span></div>
CY2023	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	2	loan
CY2022	afcg	Number Of Loans Held For Investments In Portfolio NumberOfLoansHeldForInvestmentsInPortfolio	3	loan
CY2023Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	94200000	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Aggregate Commitments LoansHeldForInvestmentAtFairValueAggregateCommitments	104300000	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71900000	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102400000	usd
CY2023	afcg	Loans Held For Investment At Fair Value Funded Of Outstanding Principal LoansHeldForInvestmentAtFairValueFundedOfOutstandingPrincipal	1900000	usd
CY2023	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	34900000	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2023	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2022	afcg	Number Of Loans Held For Investments NumberOfLoansHeldForInvestments	9	loan
CY2023Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	333100000	usd
CY2022Q4	afcg	Loans Held For Investment At Carrying Value Aggregate Commitments LoansHeldForInvestmentAtCarryingValueAggregateCommitments	338900000	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2023	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P0Y4M24D
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	100635985	usd
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022	afcg	Loans Held For Investment At Fair Value Weighted Average Remaining Life LoansHeldForInvestmentAtFairValueWeightedAverageRemainingLife	P1Y2M12D
CY2022Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	102376546	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	1740561	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-1409934	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2023	afcg	Loans Held For Investment Realized Gain Loss On Loans At Fair Value Net LoansHeldForInvestmentRealizedGainLossOnLoansAtFairValueNet	-1213416	usd
CY2023	afcg	Loans Held For Investment At Fair Value Realized Gain Loss On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueRealizedGainLossOnLoansAtFairValueNet	-1213416	usd
CY2023	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-8513364	usd
CY2023	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-8513364	usd
CY2023	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	1881840	usd
CY2023	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	1881840	usd
CY2023	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	1501162	usd
CY2023	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	1501162	usd
CY2023	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	34900946	usd
CY2023	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	34900946	usd
CY2023	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	3739378	usd
CY2023	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	3739378	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	239399	usd
CY2023Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-9923298	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2021Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	77630742	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	2717584	usd
CY2021Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	2183161	usd
CY2021Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	77096319	usd
CY2022	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueUnrealizedGainsLossesChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-3593095	usd
CY2022	afcg	Loans Held For Investment At Fair Value Change In Unrealized Gains Losses On Loans At Fair Value Net LoansHeldForInvestmentAtFairValueChangeInUnrealizedGainsLossesOnLoansAtFairValueNet	-3593095	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal New Fundings LoansHeldForInvestmentAtFairValueOutstandingPrincipalNewFundings	26605796	usd
CY2022	afcg	Loans Held For Investment At Fair Value Original Issue Discount New Funding LoansHeldForInvestmentAtFairValueOriginalIssueDiscountNewFunding	-479275	usd
CY2022	afcg	Loans Held For Investment At Fair Value New Funding LoansHeldForInvestmentAtFairValueNewFunding	26126521	usd
CY2022	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value Outstanding Principal ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValueOutstandingPrincipal	5397191	usd
CY2022	afcg	Proceeds From Principal Repayments Of Loans Held For Investment At Fair Value ProceedsFromPrincipalRepaymentsOfLoansHeldForInvestmentAtFairValue	5397191	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal Loan Amortization LoansHeldForInvestmentAtFairValueOutstandingPrincipalLoanAmortization	-1089776	usd
CY2022	afcg	Loans Held For Investment At Fair Value Loan Amortization LoansHeldForInvestmentAtFairValueLoanAmortization	-1089776	usd
CY2022	afcg	Loans Held For Investment At Fair Value Original Issue Discount Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscountAccretionOfOriginalIssueDiscount	1456298	usd
CY2022	afcg	Loans Held For Investment At Fair Value Accretion Of Original Issue Discount LoansHeldForInvestmentAtFairValueAccretionOfOriginalIssueDiscount	1456298	usd
CY2022	afcg	Loans Held For Investment At Fair Value Outstanding Principal Payment In Kind Interest LoansHeldForInvestmentAtFairValueOutstandingPrincipalPaymentInKindInterest	4626975	usd
CY2022	afcg	Loans Held For Investment At Fair Value Payment In Kind Interest LoansHeldForInvestmentAtFairValuePaymentInKindInterest	4626975	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Original Issue Discount LoansHeldForInvestmentAtFairValueOriginalIssueDiscount	1740561	usd
CY2022Q4	afcg	Loans Held For Investment At Fair Value Unrealized Gains Losses LoansHeldForInvestmentAtFairValueUnrealizedGainsLosses	-1409934	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	afcg	Loans Held For Investment Cost LoansHeldForInvestmentCost	71644003	usd
CY2023Q4	afcg	Loans Held For Investment Outstanding Principal Amount LoansHeldForInvestmentOutstandingPrincipalAmount	71883402	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2023Q4	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	1300000	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314376929	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2022Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2023Q4	afcg	Number Of Portfolio Loans NumberOfPortfolioLoans	1	loan
CY2023Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2022Q4	afcg	Loans Receivable At Carrying Value Aggregate Commitments LoansReceivableAtCarryingValueAggregateCommitments	4000000	usd
CY2023Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2000000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2200000	usd
CY2023	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	200000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2222339	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2220653	usd
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	180595	usd
CY2023	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	180595	usd
CY2023Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2040058	usd
CY2021Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2533266	usd
CY2021Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	2678	usd
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2530588	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	337114	usd
CY2022	afcg	Payments On Loans Receivable Carrying Value PaymentsOnLoansReceivableCarryingValue	337114	usd
CY2022	afcg	Accretion Of Original Issue Discount AccretionOfOriginalIssueDiscount	992	usd
CY2022	afcg	Accretion Of Original Issue Discount At Carrying Value AccretionOfOriginalIssueDiscountAtCarryingValue	992	usd
CY2022	afcg	Paid In Kind Interest Principal PaidInKindInterestPrincipal	26187	usd
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	26187	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2222339	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1686	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	2220653	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	2200000	usd
CY2023Q4	afcg	Loans Held For Investment And Financing Receivable Before Allowance For Credit Loss LoansHeldForInvestmentAndFinancingReceivableBeforeAllowanceForCreditLoss	303305456	usd
CY2023Q4	afcg	Interest Receivables InterestReceivables	2680188	usd
CY2023Q4	afcg	Payment In Kind Receivable PaymentInKindReceivable	1009974	usd
CY2023Q4	afcg	Unused Fees Receivable UnusedFeesReceivable	25833	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	3715995	usd
CY2023	afcg	Number Of Loans Included In Loan Funded Interest Reserve NumberOfLoansIncludedInLoanFundedInterestReserve	0	loan
CY2023	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	4700000	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4782271	usd
CY2023	afcg	New Reserves Interest NewReservesInterest	1526065	usd
CY2022	afcg	New Reserves Interest NewReservesInterest	12648888	usd
CY2023	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	4727009	usd
CY2022	afcg	Reserves Disbursed Interest ReservesDisbursedInterest	14230215	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3200944	usd
CY2022Q2	afcg	Line Of Credit Facility Accordion Feature Increase Limit LineOfCreditFacilityAccordionFeatureIncreaseLimit	100000000.0	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	5358667	usd
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	47915	usd
CY2023	us-gaap	Interest Expense InterestExpense	6357457	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	5807152	usd
CY2022	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	85417	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	921506	usd
CY2022	us-gaap	Interest Expense InterestExpense	6814075	usd
CY2023Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	431239913	usd
CY2022Q4	afcg	Contractual Obligation Loan Commitments ContractualObligationLoanCommitments	447101864	usd
CY2023Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	421239913	usd
CY2022Q4	afcg	Contractual Obligation Drawn Loan Commitments ContractualObligationDrawnLoanCommitments	401476418	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	10000000	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	45625446	usd
CY2023Q1	afcg	Severance Cobra Premiums Paid Percentage SeveranceCOBRAPremiumsPaidPercentage	1
CY2023Q1	afcg	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Number Of Tranches ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingNumberOfTranches	1	tranche
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	700000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	0	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3000000	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.50
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	61500000	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3291832	shares
CY2022Q1	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	67500000	usd
CY2022Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	63000000.0	usd
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	20000000	usd
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	206304	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	293420	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2168328	shares
CY2022Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedCumulativeNumberOfShares	2081212	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2022Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises Cumulative ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesCumulative	5511	shares
CY2023Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	200169	shares
CY2022Q4	afcg	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Cumulative Number Of Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedCumulativeNumberOfShares	88749	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2280372	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1300000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2280372	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.75
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	111420	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.98
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2168952	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.74
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314400000	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296600000	usd
CY2023	afcg	Loans Held For Investment At Carrying Value Outstanding Principal New Fundings LoansHeldForInvestmentAtCarryingValueOutstandingPrincipalNewFundings	59100000	usd
CY2023	afcg	Receivable With Imputed Interest Loan Repayments And Amortization Payments ReceivableWithImputedInterestLoanRepaymentsAndAmortizationPayments	23900000	usd
CY2023	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	24600000	usd
CY2023Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.84
CY2022Q4	afcg	Percentage Of Loans Held With Floating Interest Rates PercentageOfLoansHeldWithFloatingInterestRates	0.73
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2023	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P2Y2M12D
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2022	afcg	Loans Held For Investment Weighted Average Remaining Life LoansHeldForInvestmentWeightedAverageRemainingLife	P3Y1M6D
CY2022Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	296584529	usd
CY2022Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	11407417	usd
CY2022Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	285177112	usd
CY2023	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	59088860	usd
CY2023	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	7713475	usd
CY2023	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	51375385	usd
CY2023	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	4642670	usd
CY2023	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	4642670	usd
CY2023	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	18600105	usd
CY2023	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	18600105	usd
CY2023	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	24606578	usd
CY2023	afcg	Receivable With Imputed Interest Sale Of Loans Original Issue Discount ReceivableWithImputedInterestSaleOfLoansOriginalIssueDiscount	1366691	usd
CY2023	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	23239887	usd
CY2023	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	7192354	usd
CY2023	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	7192354	usd
CY2023	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	5282131	usd
CY2023	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	5282131	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	314376929	usd
CY2023Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13111531	usd
CY2023Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	301265398	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Face Amount ReceivableWithImputedInterestFaceAmount	270841715	usd
CY2021Q4	us-gaap	Receivable With Imputed Interest Discount ReceivableWithImputedInterestDiscount	13678219	usd
CY2021Q4	afcg	Loans Held For Investment Carrying Value LoansHeldForInvestmentCarryingValue	257163496	usd
CY2022	afcg	Receivable With Imputed Interest New Funding Face Amount ReceivableWithImputedInterestNewFundingFaceAmount	173685505	usd
CY2022	afcg	Receivable With Imputed Interest Discount On New Funding ReceivableWithImputedInterestDiscountOnNewFunding	8035600	usd
CY2022	afcg	Receivable With Imputed Interest New Funding Net Amount ReceivableWithImputedInterestNewFundingNetAmount	165649905	usd
CY2022	afcg	Receivable With Accretion Of Original Issue Discount Premium ReceivableWithAccretionOfOriginalIssueDiscountPremium	10306402	usd
CY2022	afcg	Accretion Of Original Issue Discount Net Amount AccretionOfOriginalIssueDiscountNetAmount	10306402	usd
CY2022	afcg	Receivable With Imputed Interest Loan Repayments Face Amount ReceivableWithImputedInterestLoanRepaymentsFaceAmount	138807472	usd
CY2022	afcg	Receivable With Imputed Interest Loan Repayments ReceivableWithImputedInterestLoanRepayments	138807472	usd
CY2022	afcg	Receivable With Imputed Interest Sale Of Loans Face Amount ReceivableWithImputedInterestSaleOfLoansFaceAmount	10000000	usd
CY2022	afcg	Receivable With Sale Of Loans Net Amount ReceivableWithSaleOfLoansNetAmount	10000000	usd
CY2022	afcg	Receivable With Paid In Kind Interest Face Amount ReceivableWithPaidInKindInterestFaceAmount	3715966	usd
CY2022	afcg	Receivable With Paid In Kind Interest Net Amount ReceivableWithPaidInKindInterestNetAmount	3715966	usd
CY2022	afcg	Receivable With Imputed Interest Amortization Payments ReceivableWithImputedInterestAmortizationPayments	2851185	usd
CY2022	afcg	Receivable With Imputed Interest Loan Amortization Payments ReceivableWithImputedInterestLoanAmortizationPayments	2851185	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2079171	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	17.67
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y3M
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	20951999	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	35932397	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	15000	usd
CY2023	us-gaap	Dividends Dividends	262394	usd
CY2022	us-gaap	Dividends Dividends	135299	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	20674605	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	20674605	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	35782098	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	35782098	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20321091	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19842222	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24828	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	115515	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20345919	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19957737	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.80
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.79
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2336146	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1401200	shares
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1700000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1546216	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	953324	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	113121	usd
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	73000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1659337	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1026324	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1200000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	300000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	800000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	200000	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	100000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	100000	usd
CY2023	afcg	Exercise Tax As A Percentage Of Undistributed Ordinary Income And Net Capital Gains ExerciseTaxAsAPercentageOfUndistributedOrdinaryIncomeAndNetCapitalGains	0.04
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	61720705	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	61720705	usd
CY2022Q4	us-gaap	Loans Receivable Fair Value Disclosure LoansReceivableFairValueDisclosure	99226051	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	99226051	usd
CY2023	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
CY2022	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	-200000	usd
CY2023	afcg	Incentive Compensation IncentiveCompensation	10400000	usd
CY2022	afcg	Incentive Compensation IncentiveCompensation	12300000	usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	17654899	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	19741562	usd
CY2023	us-gaap	Loan Processing Fee LoanProcessingFee	1100000	usd
CY2023Q4	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	1300000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.23
CY2022	afcg	Taxable Ordinary Income Per Share TaxableOrdinaryIncomePerShare	2.23
CY2022	afcg	Qualified Dividends QualifiedDividends	0
CY2022	afcg	Return Of Capital Distribution Per Share ReturnOfCapitalDistributionPerShare	0
CY2022	afcg	Section199 A Dividends Section199ADividends	2.23
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.00
CY2023	afcg	Taxable Ordinary Income Per Share TaxableOrdinaryIncomePerShare	1.85
CY2023	afcg	Qualified Dividends QualifiedDividends	0.15
CY2023	afcg	Return Of Capital Distribution Per Share ReturnOfCapitalDistributionPerShare	0
CY2023	afcg	Section199 A Dividends Section199ADividends	1.85

Files In Submission

Name	View Source	Status
0001822523-24-000014-index-headers.html	Edgar Link	pending
0001822523-24-000014-index.html	Edgar Link	pending
0001822523-24-000014.txt	Edgar Link	pending
0001822523-24-000014-xbrl.zip	Edgar Link	pending
afcg-20231231.htm	Edgar Link	pending
afcg-20231231.xsd	Edgar Link	pending
afcg-20231231xex311.htm	Edgar Link	pending
afcg-20231231xex312.htm	Edgar Link	pending
afcg-20231231xex321.htm	Edgar Link	pending
afcg-20231231xex322.htm	Edgar Link	pending
afcg-20231231_g1.jpg	Edgar Link	pending
afcg-20231231_g2.jpg	Edgar Link	pending
afcm-bhetzelemploymentagre.htm	Edgar Link	pending
consentafcg10-k.htm	Edgar Link	pending
ex211listofsubsidiariesoft.htm	Edgar Link	pending
exhibitb-afcgxformofclawba.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
afcg-20231231_def.xml	Edgar Link	unprocessable
afcg-20231231_lab.xml	Edgar Link	unprocessable
afcg-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
afcg-20231231_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
afcg-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AFCG
Advanced Flower Capital Inc. Stock $afcg

2024 Q1 Form 10-K Financial Statement

#000182252324000014 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG Advanced Flower Capital Inc. Stock $afcg

2024 Q1 Form 10-K Financial Statement

#000182252324000014 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AFCG
Advanced Flower Capital Inc. Stock $afcg